Univ. of Virginia, School of Medicine researchers discovery – a key driver of chronic inflammation causing ageing to accelerate in human bodies. This finding can potentially lead to a position where we could slow down our natural ageing clock and so live longer,healthier lives, where many age related conditions like heart disease and devastating brain…
Recommendation of secukinumab for patients with ankylosing spondylitis In draft guidance NICE,England and Wales,recommends innovative new drug secukinumab (Cosentyx, Novartis) for treating ankylosing spondylitis. Ankylosing spondylitis is a type of arthritis that mainly affects the back. Secukinumab was licensed for use in UK in May, is first in a new class of drug to treat…